Acute Parvovirus B19 Infection Leading to Severe Aplastic Anemia in a Previously Healthy Adult Female

  • Rajesh Rajput
  • Ashish Sehgal
  • Deepak Jain
  • Rajeev Sen
  • Abhishek Gupta
Case Report


Human Parvovirus B19 has been linked to a variety of diseases. One of the most common complications is transient aplastic crisis in patients with chronic hemolytic anemia. Very few case reports have implicated this virus as a putative etiology behind hepatitis and severe aplastic anemia in immuno competent individuals. We report a case of severe aplastic anemia in a previously healthy adult female due to acute parvovirus B19 infection. Laboratory examination showed pancytopenia in peripheral blood and severe hypoplastic bone marrow on biopsy. Serological analysis (ELISA) revealed acute Parvovirus B19 infection. In the face of unavailable HLA matched bone marrow donor, immuno-supressive therapy was contemplated, but could not be given because of financial constraints. Pancytopenia persists till date, 4 months after the diagnosis, with the patient requiring repeated packed red cell and irradiated platelet transfusions. Thus, acute infection with this virus must be considered a cause of acquired aplastic anemia even in individuals without underlying disease.



The authors thank Dr. Shashi Khare, Additional Director and Head (microbiology), National Centre for Disease Control, New Delhi, for kindly providing the details of ELISA kit used for detecting IgM Parvovirus B19 antibodies.


  1. 1.
    Moore TL (2000) Parvovirus-associated arthritis. Curr Opin Rheumatol 12:289–294PubMedCrossRefGoogle Scholar
  2. 2.
    Frickhofen N, Abkowitz JL, Safford M, Berry JM, Antunez-de-Mayolo J, Astrow A et al (1990) Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med 113:926–933PubMedGoogle Scholar
  3. 3.
    Frickhofen N, Chen ZJ, Young NS, Cohen BJ, Heimpel H, Abkowitz JL (1994) Parvovirus B19 as a cause of acquired chronic pure red cell aplasia. Br J Haematol 87:818–824PubMedCrossRefGoogle Scholar
  4. 4.
    Serjeant BE, Hambleton RR, Kerr S, Kilty CG, Serjeant GR (2004) Haematological response to parvovirus B19 infection in homozygous sickle-cell disease. Lancet 358:1779–1780CrossRefGoogle Scholar
  5. 5.
    Saunders PWG, Reid MM, Cohen BJ (1986) Human parvovirus induced cytopenias: a report of five cases. Br J Haematol 63:407–410PubMedCrossRefGoogle Scholar
  6. 6.
    Osaki M, Matsubara K, Iwasaki T, Kurata T, Nigami H, Harigaya H et al (1999) Severe aplastic anemia associated with human parvovirus B19 infection in a patient without underlying disease. Ann Hematol 78:83–86PubMedCrossRefGoogle Scholar
  7. 7.
    Quian XH, Zhang GC, Jiao XY, Zheng YJ, Cao YH, Xu DL et al (2002) Aplastic anemia associated with parvovirus B19 infection. Arch Dis Child 87:436–437CrossRefGoogle Scholar
  8. 8.
    Al-Abdwani RM, Khamis FA, Balkhair A, Sacharia M, Wali YA (2008) A child with human parvovirus B19 infection induced aplastic anemia and acute hepatitis: effectiveness of immunosuppressive therapy. Pediatr Hematol Oncol 25:699–703PubMedCrossRefGoogle Scholar
  9. 9.
    Yetgin S, Cetin M, Ozyurek E, Aslan D, Uckan D (2004) Parvovirus b19 infection associated with severe aplastic anemia in an immunocompetent patient. Pediatr Hematol Oncol 21:223–226PubMedCrossRefGoogle Scholar
  10. 10.
    Goto H, Ishida A, Fujii H, Kuroki F, Takahashi H, Ikuta K et al (2004) Successful bone marrow transplantation for severe aplastic anaemia in a patient with persistent human parvovirus B19 infection. Int J Hematol 79:384–386PubMedCrossRefGoogle Scholar
  11. 11.
    Kaptan K, Beyan C, Ural AU, Ustün C, Cetin T, Avcu F et al (2001) Successful treatment of severe aplastic anemia associated with human parvovirus B19 and Epstein-Barr virus in a healthy subject with allo-BMT. Am J Hematol 67:252–255PubMedCrossRefGoogle Scholar
  12. 12.
    Mishra B, Malhotra P, Ratho RK, Singh MP, Varma S, Varma N (2005) Human Parvovirus B19 in patients with aplastic anemia. Am J Hematol 79:166–167PubMedCrossRefGoogle Scholar
  13. 13.
    Young NS, Brown KE (2004) Mechanisms of disease: Parvovirus B19. N Engl J Med 350:586–597PubMedCrossRefGoogle Scholar
  14. 14.
    Risks associated with human parvovirus B19 infection (1989) MMWR Morb Mortal Wkly Rep 38:81–88; 93–97Google Scholar
  15. 15.
    Brown KE, Anderson SM, Young NS (1993) Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262:114–117PubMedCrossRefGoogle Scholar
  16. 16.
    Chisaka H, Morita E, Yaegashi N, Sugamura K (2003) Parvovirus B19 and the pathogenesis of anaemia. Rev Med Virol 13:347–359PubMedCrossRefGoogle Scholar
  17. 17.
    Srivastava A, Bruno E, Briddell R, Cooper R, Srivastava C, Van Besien K et al (1990) Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro. Blood 76:1997–2004PubMedGoogle Scholar
  18. 18.
    Chen MY, Hung CC, Fang CT, Hsieh SM (2001) Reconstituted immunity against persistent parvovirus B19 infection in a patient with acquired immunodeficiency syndrome after highly active antiretroviral therapy. Clin Infect Dis 32:1361–1365PubMedCrossRefGoogle Scholar

Copyright information

© Indian Society of Haematology & Transfusion Medicine 2011

Authors and Affiliations

  • Rajesh Rajput
    • 1
    • 4
  • Ashish Sehgal
    • 2
  • Deepak Jain
    • 2
  • Rajeev Sen
    • 3
  • Abhishek Gupta
    • 2
  1. 1.Department of Medicine Unit VII and EndocrinologyPt. B.D. Sharma PGIMSRohtakIndia
  2. 2.Department of MedicinePt. B.D. Sharma PGIMSRohtakIndia
  3. 3.Department of PathologyPt. B.D. Sharma PGIMSRohtakIndia
  4. 4.RohtakIndia

Personalised recommendations